Cargando…

Direct Costs of Dengue Hospitalization in Brazil: Public and Private Health Care Systems and Use of WHO Guidelines

BACKGROUND: Dengue, an arboviral disease, is a public health problem in tropical and subtropical regions worldwide. In Brazil, epidemics have become increasingly important, with increases in the number of hospitalizations and the costs associated with the disease. This study aimed to describe the di...

Descripción completa

Detalles Bibliográficos
Autores principales: Vieira Machado, Alessandra A., Estevan, Anderson Oliveira, Sales, Antonio, Brabes, Kelly Cristina da Silva, Croda, Júlio, Negrão, Fábio Juliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154670/
https://www.ncbi.nlm.nih.gov/pubmed/25188295
http://dx.doi.org/10.1371/journal.pntd.0003104
_version_ 1782333450431234048
author Vieira Machado, Alessandra A.
Estevan, Anderson Oliveira
Sales, Antonio
Brabes, Kelly Cristina da Silva
Croda, Júlio
Negrão, Fábio Juliano
author_facet Vieira Machado, Alessandra A.
Estevan, Anderson Oliveira
Sales, Antonio
Brabes, Kelly Cristina da Silva
Croda, Júlio
Negrão, Fábio Juliano
author_sort Vieira Machado, Alessandra A.
collection PubMed
description BACKGROUND: Dengue, an arboviral disease, is a public health problem in tropical and subtropical regions worldwide. In Brazil, epidemics have become increasingly important, with increases in the number of hospitalizations and the costs associated with the disease. This study aimed to describe the direct costs of hospitalized dengue cases, the financial impact of admissions and the use of blood products where current protocols for disease management were not followed. METHODS AND RESULTS: To analyze the direct costs of dengue illness and platelet transfusion in Brazil based on the World Health Organization (WHO) guidelines, we conducted a retrospective cross-sectional census study on hospitalized dengue patients in the public and private Brazilian health systems in Dourados City, Mato Grosso do Sul State, Brazil. The analysis involved cases that occurred from January through December during the 2010 outbreak. In total, we examined 8,226 mandatorily reported suspected dengue cases involving 507 hospitalized patients. The final sample comprised 288 laboratory-confirmed dengue patients, who accounted for 56.8% of all hospitalized cases. The overall cost of the hospitalized dengue cases was US $210,084.30, in 2010, which corresponded to 2.5% of the gross domestic product per capita in Dourados that year. In 35.2% of cases, blood products were used in patients who did not meet the blood transfusion criteria. The overall median hospitalization cost was higher (p = 0.002) in the group that received blood products (US $1,622.40) compared with the group that did not receive blood products (US $550.20). CONCLUSION: The comparative costs between the public and the private health systems show that both the hospitalization of and platelet transfusion in patients who do not meet the WHO and Brazilian dengue guidelines increase the direct costs, but not the quality, of health care.
format Online
Article
Text
id pubmed-4154670
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41546702014-09-08 Direct Costs of Dengue Hospitalization in Brazil: Public and Private Health Care Systems and Use of WHO Guidelines Vieira Machado, Alessandra A. Estevan, Anderson Oliveira Sales, Antonio Brabes, Kelly Cristina da Silva Croda, Júlio Negrão, Fábio Juliano PLoS Negl Trop Dis Research Article BACKGROUND: Dengue, an arboviral disease, is a public health problem in tropical and subtropical regions worldwide. In Brazil, epidemics have become increasingly important, with increases in the number of hospitalizations and the costs associated with the disease. This study aimed to describe the direct costs of hospitalized dengue cases, the financial impact of admissions and the use of blood products where current protocols for disease management were not followed. METHODS AND RESULTS: To analyze the direct costs of dengue illness and platelet transfusion in Brazil based on the World Health Organization (WHO) guidelines, we conducted a retrospective cross-sectional census study on hospitalized dengue patients in the public and private Brazilian health systems in Dourados City, Mato Grosso do Sul State, Brazil. The analysis involved cases that occurred from January through December during the 2010 outbreak. In total, we examined 8,226 mandatorily reported suspected dengue cases involving 507 hospitalized patients. The final sample comprised 288 laboratory-confirmed dengue patients, who accounted for 56.8% of all hospitalized cases. The overall cost of the hospitalized dengue cases was US $210,084.30, in 2010, which corresponded to 2.5% of the gross domestic product per capita in Dourados that year. In 35.2% of cases, blood products were used in patients who did not meet the blood transfusion criteria. The overall median hospitalization cost was higher (p = 0.002) in the group that received blood products (US $1,622.40) compared with the group that did not receive blood products (US $550.20). CONCLUSION: The comparative costs between the public and the private health systems show that both the hospitalization of and platelet transfusion in patients who do not meet the WHO and Brazilian dengue guidelines increase the direct costs, but not the quality, of health care. Public Library of Science 2014-09-04 /pmc/articles/PMC4154670/ /pubmed/25188295 http://dx.doi.org/10.1371/journal.pntd.0003104 Text en © 2014 Machado et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Vieira Machado, Alessandra A.
Estevan, Anderson Oliveira
Sales, Antonio
Brabes, Kelly Cristina da Silva
Croda, Júlio
Negrão, Fábio Juliano
Direct Costs of Dengue Hospitalization in Brazil: Public and Private Health Care Systems and Use of WHO Guidelines
title Direct Costs of Dengue Hospitalization in Brazil: Public and Private Health Care Systems and Use of WHO Guidelines
title_full Direct Costs of Dengue Hospitalization in Brazil: Public and Private Health Care Systems and Use of WHO Guidelines
title_fullStr Direct Costs of Dengue Hospitalization in Brazil: Public and Private Health Care Systems and Use of WHO Guidelines
title_full_unstemmed Direct Costs of Dengue Hospitalization in Brazil: Public and Private Health Care Systems and Use of WHO Guidelines
title_short Direct Costs of Dengue Hospitalization in Brazil: Public and Private Health Care Systems and Use of WHO Guidelines
title_sort direct costs of dengue hospitalization in brazil: public and private health care systems and use of who guidelines
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154670/
https://www.ncbi.nlm.nih.gov/pubmed/25188295
http://dx.doi.org/10.1371/journal.pntd.0003104
work_keys_str_mv AT vieiramachadoalessandraa directcostsofdenguehospitalizationinbrazilpublicandprivatehealthcaresystemsanduseofwhoguidelines
AT estevanandersonoliveira directcostsofdenguehospitalizationinbrazilpublicandprivatehealthcaresystemsanduseofwhoguidelines
AT salesantonio directcostsofdenguehospitalizationinbrazilpublicandprivatehealthcaresystemsanduseofwhoguidelines
AT brabeskellycristinadasilva directcostsofdenguehospitalizationinbrazilpublicandprivatehealthcaresystemsanduseofwhoguidelines
AT crodajulio directcostsofdenguehospitalizationinbrazilpublicandprivatehealthcaresystemsanduseofwhoguidelines
AT negraofabiojuliano directcostsofdenguehospitalizationinbrazilpublicandprivatehealthcaresystemsanduseofwhoguidelines